Biomedical researchers are dismayed over a patent dispute that could threaten an innovative method for sequencing genomes. Sequencing giant Illumina said on 23 February that it has filed a lawsuit against UK-based Oxford Nanopore Technologies, the first company to commercialize nanopore sequencing. The technology reads single bases of genetic material as they pass through a nanoscale pore. The suit, by ... Read More »